You have 9 free searches left this month | for more free features.

Condition

Multiple Myeloma (9)

Relapsed or Refractory Multiple Myeloma (2)

Hematologic Malignancies (1)

Hematological Malignancies (1)

High-Risk de Novo Multiple Myeloma (1)

High-risk Smoldering Multiple Myeloma (1)

Relapsed/ Refractory Multiple Myeloma (1)

Smoldering Multiple Myeloma (1)

Overall Status

Recruiting (8)

Not yet recruiting (5)

Active, not recruiting (1)

Available (1)

Phase

phase 2 (6)

phase 3 (4)

phase 1 (3)

phase 1/phase 2 (1)

Sponsor

Janssen Research & Development, LLC (8)

European Myeloma Network (1)

Irene Ghobrial, MD (1)

Janssen Pharmaceutical K.K. (1)

PETHEMA Foundation (1)

SCRI Development Innovations, LLC (1)

University Hospital, Lille (1)

University of Miami (1)

Collaborator

Janssen Research & Development, LLC (2)

Janssen Pharmaceutica (1)

Janssen Scientific Affairs, LLC (1)

Janssen, LP (1)

Study Documents

Intervention Type

drug (15)

Funder Type

Industry (9)

Other (6)

Study Type

Interventional (14)

Expanded Access (1)

teclistamab

Showing 26 - 15 of 15

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED